Zobrazeno 1 - 10 of 20 pro vyhledávání: '"Kajsa Ericson-Lindquist"'
1
Akademický článek
Targeted sequencing may facilitate differential diagnostics of pulmonary tumours: a case series
Autor: Kajsa Ericson-Lindquist, Anna Johansson, Per Levéen, Göran Elmberger, Göran Jönsson, Johan Staaf, Hans Brunnström
Publikováno v: Diagnostic Pathology, Vol 12, Iss 1, Pp 1-14 (2017)
Abstract Background Histopathological diagnosis is important for prognostication and choice of treatment in patients with cancer in the lung. Metastases to the lungs are common and need to be distinguished from primary lung cancer. Furthermore, cases
Externí odkaz: https://doaj.org/article/2e7d2794f8b8450ca04523cbbc8f2885
Zobrazit plný text záznamu
2
Akademický článek
Clinical Utility of Targeted Sequencing in Lung Cancer: Experience From an Autonomous Swedish Health Care Center
Autor: Sofi Isaksson, MD, PhD, Bassam Hazem, MD, Mats Jönsson, PhD, Christel Reuterswärd, MSc, Anna Karlsson, PhD, Håkan Griph, MD, Jens Engleson, MD, Gudrun Oskarsdottir, MD, PhD, Ronny Öhman, MD, PhD, Karolina Holm, PhD, Frida Rosengren, MSc, Karin Annersten, BSc, Göran Jönsson, PhD, Åke Borg, PhD, Anders Edsjö, MD, PhD, Per Levéen, PhD, Hans Brunnström, MD, PhD, Kajsa Ericson Lindquist, MD, PhD, Johan Staaf, PhD, Maria Planck, MD, PhD
Publikováno v: JTO Clinical and Research Reports, Vol 1, Iss 1, Pp 100013- (2020)
Objectives: Mutation analysis by massive parallel sequencing (MPS) is routinely performed in the clinical management of lung cancer in Sweden. We describe the clinical and mutational profiles of lung cancer patients subjected to the first 1.5 years o
Externí odkaz: https://doaj.org/article/53ddcb953dc24827baf6b71f1fbffe14
Zobrazit plný text záznamu
3
Akademický článek
Real-World Diagnostic Accuracy and Use of Immunohistochemical Markers in Lung Cancer Diagnostics
Autor: Kajsa Ericson Lindquist, Inga Gudinaviciene, Nektaria Mylona, Rodrigo Urdar, Maria Lianou, Eva Darai-Ramqvist, Felix Haglund, Mátyás Béndek, Erika Bardoczi, Katalin Dobra, Hans Brunnström
Publikováno v: Biomolecules, Vol 11, Iss 11, p 1721 (2021)
Objectives: Accurate and reliable diagnostics are crucial as histopathological type influences selection of treatment in lung cancer. The aim of this study was to evaluate real-world accuracy and use of immunohistochemical (IHC) staining in lung canc
Externí odkaz: https://doaj.org/article/28c57976469e4a1787e0dc9d74c128b4
Zobrazit plný text záznamu
5
PD-L1 Testing in Cytological Non-Small Cell Lung Cancer Specimens: A Comparison with Biopsies and Review of the Literature
Autor: Maria Planck, Lena Tran, Despoina Violidaki, Mohammed S. I. Mansour, Tomas Seidal, Benjamin Holmgren, Annika Dejmek, Kim Hejny, Katalin Dobra, Kajsa Ericson Lindquist, Rikard Mohlin, Hans Brunnström, Ulrich Mager
Publikováno v: Acta Cytol
Introduction: Programmed death-ligand 1 (PD-L1) expression is used for treatment prediction in non-small cell lung cancer (NSCLC). While cytology may be the only available material in the routine clinical setting, testing in clinical trials has mainl
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b730b752be77e0e94f5157abf0cc3c6
https://doi.org/10.1159/000517078
Zobrazit plný text záznamu
6
PD-L1 Expression in Non-Small Cell Lung Cancer Specimens: Association with Clinicopathological Factors and Molecular Alterations
Autor: Brunnström, Mohammed S. I. Mansour, Karina Malmros, Ulrich Mager, Kajsa Ericson Lindquist, Kim Hejny, Benjamin Holmgren, Tomas Seidal, Annika Dejmek, Katalin Dobra, Maria Planck, Hans
Publikováno v: International Journal of Molecular Sciences; Volume 23; Issue 9; Pages: 4517
Immune checkpoint inhibitors (ICI) targeting programmed cell death-1 or its ligand (PD-L1) have improved outcomes in non-small cell lung cancer (NSCLC). High tumor PD-L1 expression, detected by immunohistochemistry (IHC) typically on formalin-fixed p
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=multidiscipl::10e243b1fc6ffe9ebb39d154d29df4d8
Zobrazit plný text záznamu
7
PD-L1 Expression in Non-Small Cell Lung Cancer Specimens: Association with Clinicopathological Factors and Molecular Alterations
Autor: Mohammed S I, Mansour, Karina, Malmros, Ulrich, Mager, Kajsa, Ericson Lindquist, Kim, Hejny, Benjamin, Holmgren, Tomas, Seidal, Annika, Dejmek, Katalin, Dobra, Maria, Planck, Hans, Brunnström
Publikováno v: International journal of molecular sciences. 23(9)
Immune checkpoint inhibitors (ICI) targeting programmed cell death-1 or its ligand (PD-L1) have improved outcomes in non-small cell lung cancer (NSCLC). High tumor PD-L1 expression, detected by immunohistochemistry (IHC) typically on formalin-fixed p
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::fd7848056da6fac306e38a60f7923df6
https://pubmed.ncbi.nlm.nih.gov/35562908
Zobrazit plný text záznamu
8
Real-World Diagnostic Accuracy and Use of Immunohistochemical Markers in Lung Cancer Diagnostics
Autor: Maria Lianou, Nektaria Mylona, Matyas Bendek, Katalin Dobra, Hans Brunnström, Kajsa Ericson Lindquist, Inga Gudinaviciene, Eva Darai-Ramqvist, Rodrigo Urdar, Felix Haglund, Erika Bardoczi
Publikováno v: Biomolecules, Vol 11, Iss 1721, p 1721 (2021)
Biomolecules
Volume 11
Issue 11
Objectives: Accurate and reliable diagnostics are crucial as histopathological type influences selection of treatment in lung cancer. The aim of this study was to evaluate real-world accuracy and use of immunohistochemical (IHC) staining in lung canc
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53b4c366a55a7cf91633a06585847b3a
https://www.mdpi.com/2218-273X/11/11/1721
Zobrazit plný text záznamu
9
Predictive molecular pathology in the time of coronavirus disease (COVID-19) in Europe
Autor: Miguel Angel Molina Vila, Fernando Schmitt, Matteo Fassan, Umberto Malapelle, Elisa Gruppioni, Kajsa Ericson Lindquist, Oliver Schildgen, Antonino Iaccarino, Massimo Barberis, Svenja Wagener-Ryczek, Elena Vigliar, Luisella Righi, Marco Volante, Ida Rapa, Hans Brunnström, Giovanni Tallini, Sabine Merkelbach-Bruse, Dario de Biase, Giancarlo Troncone, Rafael Rosell, Birgit Weynand, Giovanna De Maglio, Verena Schildgen, Claudio Bellevicine, Pasquale Pisapia, Sara Vander Borght, Paul Hofman, Gabriella Fontanini, Anaïs Pujals
Publikováno v: Journal of Clinical Pathology
Journal Of Clinical Pathology
r-IGTP: Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Universidad de Alicante (UA)
AimsLung cancer predictive biomarker testing is essential to select advanced-stage patients for targeted treatments and should be carried out without delays even during health emergencies, such as the coronavirus (COVID-19) outbreak.MethodsFifteen mo
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f37400b73f8c4b71de7201e4369a434
http://hdl.handle.net/11588/828176
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje